• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

载脂蛋白Eε4等位基因在晚发性阿尔茨海默病及其他淀粉样蛋白形成疾病中的分布情况。

Apolipoprotein E epsilon 4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases.

作者信息

Saunders A M, Schmader K, Breitner J C, Benson M D, Brown W T, Goldfarb L, Goldgaber D, Manwaring M G, Szymanski M H, McCown N

机构信息

Bryan Alzheimer's Disease Research Center, Division of Neurology, Duke University Medical Center, Durham, NC 27710.

出版信息

Lancet. 1993 Sep 18;342(8873):710-1. doi: 10.1016/0140-6736(93)91709-u.

DOI:10.1016/0140-6736(93)91709-u
PMID:8103823
Abstract

The frequency of the allele for apolipoprotein E type 4 (epsilon 4) is increased in late-onset familial and sporadic Alzheimer's disease (AD). We have examined epsilon 4 frequencies in four distinct, normal, elderly control groups and, most importantly, in patients with amyloid-forming diseases whose epsilon 4 distributions were not previously known (Creutzfeldt-Jakob disease, familial amyloidotic polyneuropathy, Down's syndrome). There were no differences between any of these controls and published control series, cementing the relevance of epsilon 4 for late-onset AD. The increase in late-onset AD was confirmed in two new series.

摘要

载脂蛋白E4(ε4)等位基因在晚发性家族性和散发性阿尔茨海默病(AD)中的频率升高。我们检测了四个不同的正常老年对照组中ε4的频率,最重要的是,检测了此前ε4分布情况未知的淀粉样蛋白形成疾病患者(克雅氏病、家族性淀粉样多神经病、唐氏综合征)中ε4的频率。这些对照组与已发表的对照系列之间没有差异,进一步证实了ε4与晚发性AD的相关性。在两个新的系列中也证实了晚发性AD中ε4频率的升高。

相似文献

1
Apolipoprotein E epsilon 4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases.载脂蛋白Eε4等位基因在晚发性阿尔茨海默病及其他淀粉样蛋白形成疾病中的分布情况。
Lancet. 1993 Sep 18;342(8873):710-1. doi: 10.1016/0140-6736(93)91709-u.
2
Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families.载脂蛋白E4等位基因的基因剂量与晚发型家族性阿尔茨海默病的风险
Science. 1993 Aug 13;261(5123):921-3. doi: 10.1126/science.8346443.
3
Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease.载脂蛋白Eε4等位基因与晚发性家族性和散发性阿尔茨海默病的关联。
Neurology. 1993 Aug;43(8):1467-72. doi: 10.1212/wnl.43.8.1467.
4
Association of apolipoprotein E4 with sporadic Alzheimer's disease is more pronounced in early onset type.载脂蛋白E4与散发性阿尔茨海默病的关联在早发型中更为明显。
Neurosci Lett. 1994 Jul 4;175(1-2):74-6. doi: 10.1016/0304-3940(94)91081-2.
5
Dose-dependent association of apolipoprotein E allele epsilon 4 with late-onset, sporadic Alzheimer's disease.载脂蛋白Eε4等位基因与晚发型散发性阿尔茨海默病的剂量依赖性关联。
Ann Neurol. 1994 Oct;36(4):656-9. doi: 10.1002/ana.410360416.
6
APOE epsilon 4 influences the manifestation of Alzheimer's disease in adults with Down's syndrome.载脂蛋白E4影响唐氏综合征成年患者阿尔茨海默病的表现。
Br J Psychiatry. 2000 May;176:468-72. doi: 10.1192/bjp.176.5.468.
7
Molecular biology of APO E alleles in Alzheimer's and non-Alzheimer's dementias.阿尔茨海默病和非阿尔茨海默病性痴呆中载脂蛋白E等位基因的分子生物学
J Neural Transm Suppl. 1996;47:205-18. doi: 10.1007/978-3-7091-6892-9_14.
8
Allele doses of apolipoprotein E type epsilon 4 in sporadic late-onset Alzheimer's disease.散发性晚发性阿尔茨海默病中载脂蛋白E ε4等位基因剂量
Am J Med Genet. 1995 Dec 18;60(6):566-9. doi: 10.1002/ajmg.1320600617.
9
Apolipoprotein E polymorphism and Alzheimer's disease.载脂蛋白E基因多态性与阿尔茨海默病
Lancet. 1993 Sep 18;342(8873):697-9. doi: 10.1016/0140-6736(93)91705-q.
10
Apolipoprotein E and Alzheimer's disease: strength of association is related to age at onset.载脂蛋白E与阿尔茨海默病:关联强度与发病年龄有关。
Dementia. 1996 Sep-Oct;7(5):251-5. doi: 10.1159/000106888.

引用本文的文献

1
Clinical Significance of APOE4 Genotyping: Potential for Personalized Therapy and Early Diagnosis of Alzheimer's Disease.APOE4基因分型的临床意义:阿尔茨海默病个性化治疗与早期诊断的潜力
J Clin Med. 2025 Aug 26;14(17):6047. doi: 10.3390/jcm14176047.
2
Benefits and Challenges of Rare Genetic Variation in Alzheimer's Disease.阿尔茨海默病中罕见基因变异的益处与挑战
Curr Genet Med Rep. 2019 Mar;7(1):53-62. doi: 10.1007/s40142-019-0161-5. Epub 2019 Feb 1.
3
Decreased Brain pH Correlated With Progression of Alzheimer Disease Neuropathology: A Systematic Review and Meta-Analyses of Postmortem Studies.
脑 pH 值降低与阿尔茨海默病神经病理学进展相关:一项基于尸检研究的系统回顾和荟萃分析。
Int J Neuropsychopharmacol. 2024 Oct 1;27(10). doi: 10.1093/ijnp/pyae047.
4
Do microbes play a role in Alzheimer's disease?微生物是否在阿尔茨海默病中发挥作用?
Microb Biotechnol. 2024 Apr;17(4):e14462. doi: 10.1111/1751-7915.14462.
5
Inflammasome signaling is dispensable for ß-amyloid-induced neuropathology in preclinical models of Alzheimer's disease.炎症小体信号对于阿尔茨海默病临床前模型中 β-淀粉样蛋白诱导的神经病理学是可有可无的。
Front Immunol. 2024 Jan 29;15:1323409. doi: 10.3389/fimmu.2024.1323409. eCollection 2024.
6
APOE4-promoted gliosis and degeneration in tauopathy are ameliorated by pharmacological inhibition of HMGB1 release.载脂蛋白 E4 促进的神经胶质增生和 tau 病中的退行性变通过 HMGB1 释放的药理学抑制得到改善。
Cell Rep. 2023 Oct 31;42(10):113252. doi: 10.1016/j.celrep.2023.113252. Epub 2023 Oct 19.
7
Exploring the diagnostic markers of essential tremor: A study based on machine learning algorithms.探索特发性震颤的诊断标志物:一项基于机器学习算法的研究。
Open Life Sci. 2023 Jun 22;18(1):20220622. doi: 10.1515/biol-2022-0622. eCollection 2023.
8
Complement receptor 1 is expressed on brain cells and in the human brain.补体受体 1 表达于脑细胞和人脑。
Glia. 2023 Jun;71(6):1522-1535. doi: 10.1002/glia.24355. Epub 2023 Feb 24.
9
The neuroimmune axis of Alzheimer's disease.阿尔茨海默病的神经免疫轴。
Genome Med. 2023 Jan 26;15(1):6. doi: 10.1186/s13073-023-01155-w.
10
Disclosure of Genetic Risk Factors for Alzheimer's Disease to Cognitively Healthy Individuals-From Current Practice towards a Personalised Medicine Scenario.向认知健康个体披露阿尔茨海默病的遗传风险因素——从当前实践到个性化医疗场景
Biomedicines. 2022 Dec 8;10(12):3177. doi: 10.3390/biomedicines10123177.